Ziv Gil, MD, PhD
November is Carcinoid, Lung and Pancreatic Cancer Awareness Month
ICRF is currently supporting several projects in the areas of carcinoid, lung and pancreatic cancer research. Meet one of the currently funded researchers working on pancreatic cancer below:
The poor clinical prognosis of pancreatic ductal adenocarcinoma (PDAC) is attributed to its tendency to metastasize and its resistance to conventional treatment. Ziv Gil, MD, PhD, of Rambam Health Care Campus, has received one of the joint ICRF-City of Hope Jacki & Bruce Barron Cancer Research Scholars’ Program grants to perform collaborative research with Laleh Melstrom, MD, in order to study how to improve chemotherapy for PDAC by concurrent treatment with two different synergistic drugs.